These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 2752105

  • 1. Microenvironmental toxicity of azidothymidine: partial sparing with hemin.
    Abraham NG, Bucher D, Niranjan U, Brown AC, Lutton JD, Distenfeld A, Ahmed T, Levere RD.
    Blood; 1989 Jul; 74(1):139-44. PubMed ID: 2752105
    [Abstract] [Full Text] [Related]

  • 2. Specificity of heme for hemopoietic recovery from AZT toxicity.
    Loewy G, Cook P, Ahmed T, Lutton JD, Nishimura M, Distenfeld A, Levere RD, Abraham NG.
    Hematol Pathol; 1992 Jul; 6(2):79-85. PubMed ID: 1607343
    [Abstract] [Full Text] [Related]

  • 3. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
    Gallicchio VS, Hughes NK, Hulette BC, Noblitt L.
    J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611
    [Abstract] [Full Text] [Related]

  • 4. Amelioration of azidothymidine-induced erythroid toxicity by hemin and stem cell factor in immune-suppressed mice.
    Hamburger AW, Chen RB.
    Exp Hematol; 1994 Apr; 22(4):348-52. PubMed ID: 7512046
    [Abstract] [Full Text] [Related]

  • 5. Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1.
    Abraham NG, Chertkov JL, Staudinger R, Jiang S, Lutton JD, Argani I, Levere RD, Kappas A.
    Exp Hematol; 1993 Feb; 21(2):263-8. PubMed ID: 7678812
    [Abstract] [Full Text] [Related]

  • 6. Hemopoietic recovery from AZT toxicity with recombinant hemoglobin in a murine model of AIDS.
    Moqattash S, Lutton JD, Abu-Hijleh MF, Abraham NG.
    Acta Haematol; 1994 Feb; 92(4):182-6. PubMed ID: 7701915
    [Abstract] [Full Text] [Related]

  • 7. Additive effect of erythropoietin and heme on murine hematopoietic recovery after azidothymidine treatment.
    Harrison J, Kappas A, Levere RD, Lutton JD, Chertkov JL, Jiang S, Abraham NG.
    Blood; 1993 Dec 15; 82(12):3574-9. PubMed ID: 8260696
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effect of azidothymidine, 2'-3'-dideoxyadenosine, and 2'-3'-dideoxycytidine on in vitro growth of hematopoietic progenitor cells from normal persons and from patients with AIDS.
    Ganser A, Greher J, Völkers B, Staszewski S, Hoelzer D.
    Exp Hematol; 1989 May 15; 17(4):321-5. PubMed ID: 2540017
    [Abstract] [Full Text] [Related]

  • 9. Role of heme metabolism in AZT-induced bone marrow toxicity.
    Lutton JD, Mathew A, Levere RD, Abraham NG.
    Am J Hematol; 1990 Sep 15; 35(1):1-5. PubMed ID: 2389764
    [Abstract] [Full Text] [Related]

  • 10. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
    Scheding S, Media JE, Nakeff A.
    Exp Hematol; 1994 Jan 15; 22(1):60-5. PubMed ID: 8282060
    [Abstract] [Full Text] [Related]

  • 11. Protection and rescue from 2',3'-dideoxypyrimidine nucleoside analog toxicity by hemin in human bone marrow progenitor cells.
    Fowler DA, Xie MY, Sommadossi JP.
    Antimicrob Agents Chemother; 1996 Jan 15; 40(1):191-5. PubMed ID: 8787904
    [Abstract] [Full Text] [Related]

  • 12. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
    Gallicchio VS, Hughes NK, Tse KF.
    Growth Regul; 1994 Jun 15; 4(2):41-7. PubMed ID: 7950902
    [Abstract] [Full Text] [Related]

  • 13. Effects of combinations of stem cell factor and hemin on erythropoiesis after azidothymidine treatment of immunosuppressed mice.
    Hamburger AW.
    Eur J Haematol; 1996 Aug 15; 57(2):128-33. PubMed ID: 8856089
    [Abstract] [Full Text] [Related]

  • 14. Synergistic cytotoxic effect of azidothymidine and recombinant interferon alpha on normal human bone marrow progenitor cells.
    Berman E, Duigou-Osterndorf R, Krown SE, Fanucchi MP, Chou J, Hirsch MS, Clarkson BD, Chou TC.
    Blood; 1989 Sep 15; 74(4):1281-6. PubMed ID: 2765664
    [Abstract] [Full Text] [Related]

  • 15. Azidothymidine and interferon-alpha in vitro effects on hematopoiesis: protective in vitro activity of IL-1 and GM-CSF.
    Castello G, Mela G, Cerruti A, Mencoboni M, Lerza R.
    Exp Hematol; 1995 Dec 15; 23(13):1367-71. PubMed ID: 7498365
    [Abstract] [Full Text] [Related]

  • 16. Protection of 3'-azido-3'-deoxythymidine induced toxicity to murine hematopoietic progenitors (CFU-GM, BFU-E and CFU-MEG) with interleukin-1.
    Gallicchio VS, Doukas MA, Hulette BC, Hughes NK, Gass C.
    Proc Soc Exp Biol Med; 1989 Nov 15; 192(2):201-4. PubMed ID: 2813453
    [Abstract] [Full Text] [Related]

  • 17. Suppression of murine hematopoiesis in vivo after chronic administration of zidovudine: evidence that zidovudine-induced anemia is the result of decreased bone marrow-derived, erythropoietin-responsive progenitor cells.
    Gallicchio VS, Hughes NK.
    Proc Soc Exp Biol Med; 1992 Apr 15; 199(4):459-65. PubMed ID: 1549625
    [Abstract] [Full Text] [Related]

  • 18. [Demonstration of a protector effect of interleukin-1 against hematologic toxicity of azidothymidine (AZT)].
    Arock M, Dedenon A, Damais C, Averlant G, Guillosson JJ.
    C R Seances Soc Biol Fil; 1992 Apr 15; 186(3):206-14. PubMed ID: 1493577
    [Abstract] [Full Text] [Related]

  • 19. Comparison of dideoxynucleoside drugs (DDI and zidovudine) and induction of hematopoietic toxicity using normal human bone marrow cells in vitro.
    Gallicchio VS, Hughes NK, Tse KF.
    Int J Immunopharmacol; 1993 Feb 15; 15(2):263-8. PubMed ID: 8468123
    [Abstract] [Full Text] [Related]

  • 20. Specificity of hemin action in vivo at early stages of hematopoietic cell differentiation.
    Monette FC, Holden SA, Sheehy MJ, Matzinger EA.
    Exp Hematol; 1984 Nov 15; 12(10):782-7. PubMed ID: 6510480
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.